About
Technology
Issues
FAQ
Links
Official Page
Risk of tuberculosis is higher with anti–tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three‐year prospective french research axed on tolerance of biotherapies registry
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.